Compare CET & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CET | ATRC |
|---|---|---|
| Founded | 1929 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | N/A | 2005 |
| Metric | CET | ATRC |
|---|---|---|
| Price | $52.37 | $34.92 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $51.17 |
| AVG Volume (30 Days) | 40.2K | ★ 1.0M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 5.12% | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $201,630,000.00 |
| Revenue This Year | N/A | $15.27 |
| Revenue Next Year | N/A | $12.21 |
| P/E Ratio | $6.93 | ★ N/A |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $47.76 | $25.36 |
| 52 Week High | $54.65 | $43.18 |
| Indicator | CET | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 46.81 | 67.81 |
| Support Level | $52.23 | $30.77 |
| Resistance Level | $52.52 | $38.42 |
| Average True Range (ATR) | 0.64 | 1.51 |
| MACD | 0.02 | 0.34 |
| Stochastic Oscillator | 40.00 | 84.93 |
Central Securities Corp is a non-diversified closed-end management investment company. The company's investment objective is long-term growth of capital. It invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.